Company: PGEN
Filing Date: 2025-08-19
Form Type: S-3
Source: 0000950103-25-010472
Chunk: 38

Company: PRECIGEN, INC.
Filing Date: 2025-08-19
Form: S-3
Chunk 38
---
 to deliver a copy of this prospectus to each purchaser at or prior to the
time of the sale (including by compliance with Rule 172 under the Securities Act).

<div align='center'>20

Legal Matters</div>

Certain legal matters relating to the issuance
and sale of the securities offered hereby will be passed upon for us by our counsel, Hogan Lovells US LLP, Baltimore, Maryland, and Davis
Polk & Wardwell LLP, New York, New York. Additional legal matters may be passed upon for us or any underwriters, dealers or agents,
by counsel that we will name in the applicable prospectus supplement.

<div align='center'>Experts</div>

The financial statements of Precigen, Inc. incorporated
by reference in this prospectus have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated
in their report. Such financial statements are incorporated by reference in reliance upon the report of such firm, given their authority
as experts in accounting and auditing.

<div align='center'>Where You Can Find
More Information</div>

We file reports, proxy statements, and other information
with the SEC. The SEC maintains a website that contains reports, proxy and information statements, and other information about issuers,
such as us, who file electronically with the SEC. The address of that website is www.sec.gov. We make available, free of charge,
on our website at www.precigen.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K
and any amendments to such reports as soon as reasonably practicable after such reports are electronically filed with, or furnished to,
the SEC.

Information on or accessible through our website
is not incorporated by reference herein and does not form a part of this prospectus.

This prospectus and any prospectus supplement
are part of a registration statement that we have filed with the SEC and do not contain all of the information in the registration statement.
The full registration statement may be obtained through the SEC’s website, as provided above, or from us, as provided in the section
of this prospectus entitled “Incorporation by Reference.” Certain documents establishing the terms of the offered securities
are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. Statements
in this prospectus or any prospectus supplement about these documents are summaries and each statement is subject, and qualified in all
respects by reference